Paul McNeice, Chief Accounting Officer at American Well Corp (NASDAQ:AMWL), conducted a sale of the company's Class A Common Stock totaling $1,090 on June 1, 2026. The specific transaction involved disposing of 112 shares, each purchased at a price of $9.74 per share.
According to documentation related to the filing, these stock sales were executed solely to cover tax obligations arising from the vesting and settlement of restricted stock units on that same date. It is important to note that this transaction was an automatic "sell to cover" mechanism and did not constitute a discretionary trade by Mr. McNeice.
Following the sale, Paul McNeice's direct holdings of American Well Class A Common Stock amount to 10,504 shares.
The timing of this routine tax-related disposition is noteworthy because AMWL shares have experienced a substantial surge of 108% over the preceding six months. However, more recently, the stock has seen a pullback, trading at $8.46 from the transaction price of $9.74.
Despite these fluctuations, an analysis provided by InvestingPro suggests that the stock remains undervalued at its current levels. The company maintains a "GOOD" financial health score, even while navigating ongoing profitability challenges.
In other corporate developments, Amwell released its first-quarter 2026 financial results. These reports indicated total revenue of $54.9 million. This figure marks an 18% decline when compared to the figures from the preceding year, a drop that was largely attributed by the company to customer churn.
Despite the decrease in overall revenue, Amwell reported significant strides toward achieving profitability. Specifically, the corporation improved its operating loss by 43%.
Furthermore, key personnel changes were announced. Amazon confirmed that Dr. Roy Schoenberg will take the lead role of its healthcare unit beginning July 1. Dr. Schoenberg previously co-founded American Well Corp and recently resigned from the company's board of directors to assume this new position at Amazon. The confirmation stated that his departure was not due to any disagreements with American Well.
On a positive note regarding product development, Amwell's SilverCloud digital behavioral health solution demonstrated favorable results during a study. This study was funded by the National Institute of Mental Health and encompassed 26 U.S. colleges and universities. The research included 6,205 students who were identified as being at an elevated risk for conditions such as anxiety, depression, or eating disorders.
The current market data reflects various trading metrics for AMWL. For instance, the stock was observed closing at $8.46$. Other recent snapshots show a price of $8.51$ after hours and a daily change of -0.47% (or -$0.04) from its previous close.